TA Director, Risk Management Lead - Multiple Therapeutic Areas (Hybrid

TA Director, Risk Management Lead - Multiple Therapeutic Areas (Hybrid)

• Full-time
• Salary Min: 160500
• Salary Max: 305000
• Workday Global Grade: 21
• Compensation: USD 160,500 - USD 305,000 - yearly

About Abb Vie

Abb Vie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about Abb Vie, please visit us at  Follow @abbvie on Linked In, Facebook, Instagram, X and You Tube.

The TA Director of Risk Management Leads is responsible for overseeing and advancing risk management strategy, practices, and performance across clinical development portfolios within Immunology, Neuroscience, Aesthetics /Eye Care /Specialty therapeutic areas. This leader drives risk identification, assessment, mitigation, and monitoring, ensuring a critical-to-quality, data-driven approach is embedded in protocol design and study operations. By developing and leading a high-performing team of Risk Management Leads, the TA Director ensures effective oversight, RAMP accountability, and continuous improvement in risk management practices, with a specific focus on addressing resource gaps related to RAMP entry work and the implementation of risk-based study modifications.

Key Responsibilities:

• Drive portfolio-level risk identification and mitigation strategies in partnership with therapeutic area teams, enhancing proactive management of study and program risks.
• Support and collaborate with the Integrated Evidence Strategy Team (IEST) to embed critical-to-quality elements into protocol design, ensuring data collection is focused on decision-making needs.
• Lead, develop, and mentor a team of Risk Management Leads, fostering expertise, collaboration, and innovation in risk-based quality management.
• Oversee the development and execution of therapeutic area risk insights, dashboards, and mitigation plans, promoting a deep understanding of risk drivers and solutions.
• Ensure robust RAMP (Risk Assessment and Mitigation Plan) processes, tracking accountability and ensuring timely, data-driven risk action planning.
• Address resource gaps by overseeing RAMP entry work and supporting the implementation of risk-based modifications to the scope of studies assigned to Study Risk Leads (SRLs), advocating for full resource needs where required.
• Collaborate with cross-functional stakeholders (including Clinical Site Management, Clinical Study Leadership, Data Science, and Compliance) to ensure alignment and consistency in risk management practices.
• Contribute to the development, standardization, and continuous improvement of risk management best practices, metrics, and training across the organization.

Impact and Influence:

• Deepens portfolio and program risk management capabilities and accountability.
• Leads a critical-to-quality, focused approach to data collection, supporting pipeline decision-making on sound data.
• Supports a culture of continuous improvement, transparency, and evidence-driven risk mitigation.

This is a hybrid position working on-site T-TH. Candidates must be local to Lake County, IL or Irvine, CA and work on-site 3 days a week.

• Minimum of a bachelor’s degree in life sciences, healthcare, pharmacy, nursing, or a related field; an advanced degree (Master’s, PharmD, PhD, MD) is strongly preferred.
• At least 15 years of experience in clinical research, clinical operations, or study/data risk management, with a minimum of 5 years in a leadership or people management capacity.
• Demonstrated expertise in risk-based quality management (RBQM), including experience applying ICH-GCP E6(R2) risk-based methodology and risk management best practices in clinical development.
• Direct hands-on experience with portfolio-level risk assessments, Risk Assessment and Mitigation Planning (RAMP), and implementing risk-based modifications across multiple clinical programs/therapeutic areas.
• Strong knowledge of relevant regulatory guidelines (FDA, EMA,…